logo

For the Inventor, By the Inventor

London, United Kingdom

Tamara Ladduwahetty

This inventor holds 28 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Sharpe & Dohme Corp.. Active years: 1993-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamara Ladduwahetty. Retrieved from https://idiyas.com/inventor/tamara-ladduwahetty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 82.1


Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 198(Granted Patents)


Location History:

  • Buckhurst Hill, GB (1993 - 2003)
  • London, GB (1996 - 2009)

Company Filing History:

goldMedal20 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal7 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal1 out of 36 
 
Merck Sharpe & Dohme Corp.
 patents

Years Active: 1993-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
GABA Receptor Ligands
Tachykinin Antagonists
Diarylsulfones
Isoxazole Derivatives
Triazolopyridazine
Piperazine Derivatives
Morpholine Compounds
Pharmaceutical Compositions
Anxiety Treatment
Cognition Enhancement
Imidazolophthalazine
Substituted Derivatives
28 patents (USPTO):Explore Patents
1. 7592456 - [object Object] (2009-09-22),
2. 7468393 - Diarylsulfones as 5-HT2A antagonists (2008-12-23),
3. 7452899 - Gamma-secretase inhibitors (2008-11-18),
4. 7217740 - Diarylsulfones as 5-HT2A antagonists (2007-05-15),
5. 7060710 - [object Object] (2006-06-13),
6. 7022724 - Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands (2006-04-04),
7. 6949549 - Imidazolophthalazine derivatives as ligands for GABAA receptors (2005-09-27),
8. 6946461 - Imidazolophthalazine derivatives as ligands for GABAA receptors (2005-09-20),
9. 6638930 - Morpholine and thiomorpholine tachykinin receptor antagonists (2003-10-28),
10. 6448249 - Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABA&agr;5 ligands (2002-09-10),
11. 6444666 - Triazolopyridazine Derivatives for treating anxiety and enhancing cognition (2002-09-03),
12. 6310203 - Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands (2001-10-30),
13. 6297235 - Triazolopyridazine derivatives for treating anxiety and enhancing cognition (2001-10-02),
14. 6235735 - Morpholine and thiomorpholine tachykinin receptor antagonists (2001-05-22),
15. 6200975 - Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands (2001-03-13),

Title: Innovations in CNS Treatments: The Contributions of Tamara Ladduwahetty

Introduction

Tamara Ladduwahetty, based in London, GB, is a prolific inventor recognized for her significant contributions to the field of medicinal chemistry. With 28 patents to her name, she has developed innovative compounds that have the potential to address various central nervous system (CNS) conditions.

Latest Patents

Among her latest patents, Tamara has worked on compounds of formula (I) that serve as potent and selective 5-HT antagonists. These compounds are useful in treating a variety of adverse conditions related to the CNS. Another notable patent she holds involves diarylsulfones as 5-HT2A antagonists, which also represents potent and selective antagonism of the human 5-HT receptor, further advancing treatments for CNS-related ailments.

Career Highlights

Tamara's impressive career includes tenures at leading pharmaceutical companies like Merck Sharp & Dohme Corporation and Merck & Company, Inc. Her work has significantly impacted the development of new therapeutic drugs focused on mental health and neurological disorders.

Collaborations

Throughout her career, Tamara has collaborated with esteemed colleagues, including Angus Murray MacLeod and Kevin John Merchant. These partnerships have facilitated a rich exchange of ideas, leading to innovative breakthroughs in her research.

Conclusion

Tamara Ladduwahetty's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through various patents are paving the way for more effective treatments for CNS conditions, showcasing the vital role of inventors in enhancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…